Pulse Biosciences, Inc.
PLSENASDAQHealthcare● Active
$24.84
$-0.49(-1.93%)
Market Cap$1.7B
P/E Ratio—
52W High$28.53
52W Low$12.56
Pulse Biosciences, Inc. (PLSE) · Balance Sheet
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · PLSE · as of 2026-06-10
Financial statements
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $80.73M | $118.04M | $44.37M | $61.14M | $28.61M |
| Net Receivables | $0.27M | $0.00M | $0.00M | $0.00M | $0.06M |
| Inventory | $0.14M | $0.00M | $0.00M | $0.00M | $5.82M |
| Total Current Assets | $83.42M | $119.45M | $45.33M | $62.15M | $36.63M |
| PP&E Net | $7.06M | $8.32M | $8.78M | $10.02M | $11.25M |
| Goodwill | $2.79M | $2.79M | $2.79M | $2.79M | $2.79M |
| Intangible Assets | $0.57M | $1.22M | $1.89M | $2.55M | $3.22M |
| Total Assets | $96.11M | $132.46M | $59.15M | $77.88M | $54.25M |
| Liabilities | |||||
| Short-Term Debt | $1.57M | $0.00M | $0.00M | $0.92M | $0.44M |
| Accounts Payable | $2.78M | $1.67M | $1.84M | $1.57M | $2.90M |
| Total Current Liabilities | $7.92M | $10.05M | $6.71M | $5.98M | $8.52M |
| Long-Term Debt | $0.00M | $0.00M | $0.00M | $65.00M | $0.00M |
| Total Liabilities | $15.46M | $17.60M | $14.79M | $80.13M | $18.56M |
| Stockholders Equity | |||||
| Retained Earnings | ($463.28M) | ($390.50M) | ($336.92M) | ($294.70M) | ($236.20M) |
| Total Stockholders Equity | $80.66M | $114.86M | $44.36M | ($2.25M) | $35.69M |
| Total Liab & Equity(computed) | $96.11M | $132.46M | $59.15M | $77.88M | $54.25M |
| Debt Summary | |||||
| Total Debt | $7.53M | $8.90M | $9.14M | $75.96M | $11.25M |
| Net Debt | ($73.20M) | ($109.14M) | ($35.22M) | $14.82M | ($17.36M) |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · M
Explore more Pulse Biosciences, Inc. data
About Pulse Biosciences, Inc. (PLSE) Balance Sheet
Pulse Biosciences, Inc. (PLSE) balance sheet shows total assets of $0.10B with cash of $0.08B. Total liabilities are $0.02B, total debt $0.01B, and stockholders equity $0.08B.
Frequently asked questions
PLSE · 4 questionsPulse Biosciences, Inc. has total debt of $0.01B with net debt of ($0.07B).
PLSE total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10